Emcure Pharmaceuticals shares surged by over 4% in early trading following impressive Q2 earnings for the quarter ending September 2024.
The company reported a 39.83% increase in net profit, reaching Rs 194.57 crore compared to Rs 139.15 crore in Q2 2023. Emcure also saw a 20.38% boost in sales, totalling Rs 2001.98 crore, up from Rs 1663.09 crore in the same period last year.
As of 9:23 am, Emcure Pharmaceuticals shares were trading 3.02% higher at Rs 1,483.35 on the NSE.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
